Abstract
Introduction
Hypoglycemia is a clinical syndrome triggered by diverse causes, among which insulinoma is a major one (1, 2) . Insulinomas are rare, the incidence being estimated at only four per one million person-year (3) . In fact, almost no institution worldwide encounters, on average, more than nine such cases per year (4) (5) (6) (7) . As many as 90% of the insulinomas have been reported as benign, 90% solitary, and 75% less than 3 cm in size (8, 9 (10, 11) .
Although several physiological secretagogues can influence insulin secretion from insulinoma, the vast majority of these tumors secrete insulin inappropriately, resulting in fasting-and exercise-induced hypoglycemia (2) . We have recently encountered a patient with insulinoma whose hypoglycemic episodes were induced only after eating or during increased physical activity, but not during fasting.
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formed. However, the effectiveness of octreotide to reduce insulin hypersecretion in this case prompted us to employ somatostatin receptor scintigraphy for tumor localization. As shown in Fig. 1 , significant radioactive uptake was noted around the pancreatic head and duodenum by 111 Inpentetreotide (Octreoscan).
At laparotomy, two distinct islet cell adenomas (6 mm and 20 mm) were identified in the uncinate process of the pancreas, which were surgically resected (Fig. 2a) . Histological examination of both tissue specimens showed similar characteristics with monotonous sheets of small round tumor cells (Fig. 2b) , consistent with the diagnosis of insulinoma. Immunohistochemical study revealed positive immunostaining for insulin (Fig. 2c) and chromogranin A (Fig. 2d) 
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T a b l e 3 . P o s t o p e r a t i v e Or a l a n d I n t r a v e n o u s Gl u c o s e T o le r a n c e T e s t s nomas (12) (13) (14) , β-cell tumors have occasionally been shown to hyperrespond to a variety of normal insulin secretagogues, such as glucagon, leucine, tolbutamide, and calcium (12, 13, (15) (16) (17) (18) (19) 
